Shell Asset Management Co. Purchases 6,087 Shares of Monsanto Company (NYSE:MON)
Shell Asset Management Co. boosted its position in shares of Monsanto Company (NYSE:MON) by 3.9% during the second quarter, Holdings Channel reports. The institutional investor owned 163,710 shares of the basic materials company’s stock after buying an additional 6,087 shares during the period. Shell Asset Management Co.’s holdings in Monsanto were worth $19,377,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares in the last quarter. York Capital Management Global Advisors LLC increased its stake in Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after buying an additional 1,506,057 shares in the last quarter. Flossbach Von Storch AG increased its stake in Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock worth $462,920,000 after buying an additional 1,034,400 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock worth $246,899,000 after buying an additional 775,520 shares in the last quarter. Finally, MARSHALL WACE ASIA Ltd purchased a new stake in Monsanto during the first quarter worth about $63,977,000. Institutional investors and hedge funds own 75.31% of the company’s stock.
Monsanto Company (MON) opened at 116.55 on Friday. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97. The company has a 50-day moving average price of $117.47 and a 200-day moving average price of $115.08. The stock has a market capitalization of $51.20 billion, a PE ratio of 25.17 and a beta of 1.07.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. During the same period last year, the company earned $2.17 earnings per share. Monsanto’s quarterly revenue was up 1.0% compared to the same quarter last year. Analysts expect that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 1.85%. The ex-dividend date is Thursday, October 5th. Monsanto’s payout ratio is currently 46.75%.
ILLEGAL ACTIVITY NOTICE: This article was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.dailypolitical.com/2017/08/13/shell-asset-management-co-purchases-6087-shares-of-monsanto-company-nysemon.html.
A number of equities research analysts have issued reports on MON shares. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target for the company in a research note on Friday, June 16th. BidaskClub downgraded Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research note on Thursday, July 6th. Susquehanna Bancshares Inc restated a “neutral” rating and set a $128.00 price target (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 price target (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and an average target price of $123.15.
In other Monsanto news, SVP Janet M. Holloway sold 3,337 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the sale, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at $5,239,790. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 74,470 shares of company stock worth $8,791,281. 0.79% of the stock is owned by corporate insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.